Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06286605Not ApplicableNot Yet Recruiting

RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A

Role: collaborator

NCT06276712Not ApplicableNot Yet Recruiting

RCT Comparing KS Versus TS for Ovedenture

Role: collaborator

NCT05843981Not ApplicableNot Yet Recruiting

Comparison KS Versus TS

Role: collaborator

All 3 trials loaded